Clinical trial
Surveillance of Safety and Efficacy of Wilate in Patients With Von Willebrand Disease
NCT01602419 is registered in ClinicalTrials.gov with Octapharma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Surveillance of Safety and Efficacy of Wilate in Patients With Von Willebrand Disease
- Lead sponsor
- Octapharma
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2012
- Completion date
- April 30, 2018
- Enrollment
- 120 (actual)
- Sites
- 24
Conditions
As the registry lists them; a condition with its own page is linked.
von willebrand disease